These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 29760134)

  • 21. In-vitro activity of the novel fluorocycline eravacycline against carbapenem non-susceptible Acinetobacter baumannii.
    Seifert H; Stefanik D; Sutcliffe JA; Higgins PG
    Int J Antimicrob Agents; 2018 Jan; 51(1):62-64. PubMed ID: 28705668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High prevalence of oxacillinases in clinical multidrug-resistant Acinetobacter baumannii isolates from the Tshwane region, South Africa - an update.
    Lowings M; Ehlers MM; Dreyer AW; Kock MM
    BMC Infect Dis; 2015 Nov; 15():521. PubMed ID: 26573617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular Epidemiology of Carbapenem-Resistant Acinetobacter baumannii in a Tertiary Care Hospital in Egypt: Clonal Spread of blaOXA-23.
    El Bannah AMS; Nawar NN; Hassan RMM; Salem STB
    Microb Drug Resist; 2018 Apr; 24(3):269-277. PubMed ID: 28783427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. OXA-Carbapenemases Present in Clinical Acinetobacter baumannii-calcoaceticus Complex Isolates from Patients in Kurdistan Region, Iraq.
    Ganjo AR; Maghdid DM; Mansoor IY; Kok DJ; Severin JA; Verbrugh HA; Kreft D; Fatah MH; Alnakshabandi AA; Dlnya A; Hammerum AM; Ng K; Goessens W
    Microb Drug Resist; 2016 Dec; 22(8):627-637. PubMed ID: 27003287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of bla
    El-Mahdy TS; Al-Agamy MH; Al-Qahtani AA; Shibl AM
    Microb Drug Resist; 2017 Jan; 23(1):115-121. PubMed ID: 27183378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. OXA-23 Is a Prevalent Mechanism Contributing to Sulbactam Resistance in Diverse Acinetobacter baumannii Clinical Strains.
    Yang Y; Xu Q; Li T; Fu Y; Shi Y; Lan P; Zhao D; Chen Q; Zhou Z; Jiang Y; Peleg AY; Yu Y
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30348663
    [No Abstract]   [Full Text] [Related]  

  • 27. In Vivo Selection of Pan-Drug Resistant Acinetobacter baumannii during Antibiotic Treatment.
    Kim Y; Bae IK; Jeong SH; Yong D; Lee K
    Yonsei Med J; 2015 Jul; 56(4):928-34. PubMed ID: 26069113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A high mortality rate associated with multidrug-resistant Acinetobacter baumannii ST79 and ST25 carrying OXA-23 in a Brazilian intensive care unit.
    da Silva KE; Maciel WG; Croda J; Cayô R; Ramos AC; de Sales RO; Kurihara MNL; Vasconcelos NG; Gales AC; Simionatto S
    PLoS One; 2018; 13(12):e0209367. PubMed ID: 30592758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Draft genome sequence of a multidrug-resistant OXA-23-producing Acinetobacter baumannii ST191 clinical isolate from China.
    Xu J; Lin W; Xi W; Yao Y
    J Glob Antimicrob Resist; 2017 Sep; 10():8-9. PubMed ID: 28572036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel mutation in pmrB mediates colistin resistance during therapy of Acinetobacter baumannii.
    Dahdouh E; Gómez-Gil R; Sanz S; González-Zorn B; Daoud Z; Mingorance J; Suárez M
    Int J Antimicrob Agents; 2017 Jun; 49(6):727-733. PubMed ID: 28438568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic characterization of extensively drug-resistant Acinetobacter baumannii strain, KAB03 belonging to ST451 from Korea.
    Lee SY; Oh MH; Yun SH; Choi CW; Park EC; Song HS; Lee H; Yi YS; Shin J; Chung C; Moon JY; Lee JC; Kim GH; Kim SI
    Infect Genet Evol; 2018 Nov; 65():150-158. PubMed ID: 30053642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of rifampicin-colistin combination against XDR Acinetobacter baumannii harbouring bla
    Ghaith D; Hassan R; Dawoud MEE; Eweis M; Metwally R; Zafer M
    Infect Dis (Lond); 2019 Apr; 51(4):308-311. PubMed ID: 30776934
    [No Abstract]   [Full Text] [Related]  

  • 33. Association of virulence gene expression with colistin-resistance in Acinetobacter baumannii: analysis of genotype, antimicrobial susceptibility, and biofilm formation.
    Bahador A; Farshadzadeh Z; Raoofian R; Mokhtaran M; Pourakbari B; Pourhajibagher M; Hashemi FB
    Ann Clin Microbiol Antimicrob; 2018 Jun; 17(1):24. PubMed ID: 29859115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The emergence of a novel sequence type of MDR Acinetobacter baumannii from the intensive care unit of an Egyptian tertiary care hospital.
    Ghaith DM; Zafer MM; Al-Agamy MH; Alyamani EJ; Booq RY; Almoazzamy O
    Ann Clin Microbiol Antimicrob; 2017 May; 16(1):34. PubMed ID: 28486994
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Soudeiha MAH; Dahdouh EA; Azar E; Sarkis DK; Daoud Z
    Front Cell Infect Microbiol; 2017; 7():209. PubMed ID: 28596943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular characterization of oxacillinases among carbapenem-resistant Acinetobacter baumannii nosocomial isolates in a Saudi hospital.
    Elabd FM; Al-Ayed MS; Asaad AM; Alsareii SA; Qureshi MA; Musa HA
    J Infect Public Health; 2015; 8(3):242-7. PubMed ID: 25466594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a Novel NDM Variant, blaNDM-3, From a Multidrug-Resistant Acinetobacter baumannii.
    Kumar M
    Infect Control Hosp Epidemiol; 2016 Jun; 37(6):747-8. PubMed ID: 27071840
    [No Abstract]   [Full Text] [Related]  

  • 38. Investigation of Extensively Drug-Resistant blaOXA-23-Producing Acinetobacter baumannii Spread in a Greek Hospital.
    Mavroidi A; Katsiari M; Palla E; Likousi S; Roussou Z; Nikolaou C; Platsouka ED
    Microb Drug Resist; 2017 Jun; 23(4):488-493. PubMed ID: 27728770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance.
    Qureshi ZA; Hittle LE; O'Hara JA; Rivera JI; Syed A; Shields RK; Pasculle AW; Ernst RK; Doi Y
    Clin Infect Dis; 2015 May; 60(9):1295-303. PubMed ID: 25632010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular characterization of carbapenem-insensitive Acinetobacter baumannii in Egypt.
    Al-Agamy MH; Khalaf NG; Tawfick MM; Shibl AM; El Kholy A
    Int J Infect Dis; 2014 May; 22():49-54. PubMed ID: 24607428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.